Low-dose inhalation of interleukin-2 bio-chemotherapy for the treatment of pulmonary metastases in melanoma patients

por Posch, C, Weihsengruber, F, Bartsch, K, Feichtenschlager, V, Sanlorenzo, M, Vujic, I, Monshi, B, Ortiz-Urda, S, Rappersberger, K
Publicado 2014

Combined inhibition of MEK and Plk1 has synergistic anti-tumor activity in NRAS mutant melanoma

por Posch, C, Cholewa, BD, Vujic, I, Sanlorenzo, M, Ma, J, Kim, ST, Kleffel, S, Schatton, T, Rappersberger, K, Gutteridge, R, Ahmad, N, Ortiz/Urda, S
Publicado 2015